Riding the Wave of Adalimumab Biosimilars: Considerations for Pediatric Gastroenterologists

被引：0
|
作者：
White, Shannon [1 ,2 ,3 ]
Morrow, Ryan [2 ,3 ,4 ]
Pan, Ingrid [1 ,5 ]
de Zoeten, Edwin F. [2 ,3 ,4 ,6 ]
机构：
[1] Childrens Hosp Colorado, Dept Pharm, Aurora, CO USA
[2] Childrens Hosp Colorado, Digest Hlth Inst, Aurora, CO USA
[3] Childrens Hosp Colorado, Inflammatory Bowel Dis Ctr, Aurora, CO USA
[4] Univ Colorado, Dept Pediat, Anschutz Sch Med, Aurora, CO USA
[5] Childrens Colorado Div Rheumatol, Aurora, CO USA
[6] Childrens Hosp Colorado, Digest Hlth Inst, 13123 East 16th Ave B290, Aurora, CO 80045 USA
来源：
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION | 2023年 / 76卷 / 06期
关键词：
adalimumab; biosimilar; inflammatory bowel disease;
D O I：
10.1097/MPG.0000000000003757
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：701 / 703
页数：3
相关论文
共 50 条
  • [1] Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave [Podcast]
    Cohen, Stanley B.
    Leach, Mariah Z.
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2023, 15 : 207 - 212
  • [2] Adalimumab and the Challenges for Biosimilars
    Gellad, Walid F.
    Good, Chester B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (22): : 2171 - 2172
  • [3] Key design considerations on comparative clinical efficacy studies for biosimilars: adalimumab as an example
    Lai, Zhihong
    La Noce, Anna
    RMD OPEN, 2016, 2 (01):
  • [4] Biosimilars in Pediatric IBD: Updated Considerations for Disease Management
    Dipasquale, Valeria
    Cucinotta, Ugo
    Romano, Claudio
    BIOLOGICS-TARGETS & THERAPY, 2022, 16 : 57 - 66
  • [5] IMPLEMENTATION OF ADALIMUMAB BIOSIMILARS IN DENMARK
    Jensen, T. B.
    Andersen, Traerup J.
    Kim, S. C.
    Kjellberg, J.
    Bartels, D.
    Christensen, Rolighed H.
    Solem, Jimenez E.
    VALUE IN HEALTH, 2019, 22 : S425 - S425
  • [6] A PHARMACEUTICAL GUIDE TO ADALIMUMAB BIOSIMILARS
    Almaaytah, Ammar
    FARMACIA, 2022, 70 (03) : 379 - 385
  • [7] Biosimilars of adalimumab: the upcoming challenge in IBD
    Fiorino, Gionata
    Gilardi, Daniela
    Correale, Carmen
    Furfaro, Federica
    Roda, Giulia
    Loy, Laura
    Argollo, Marjorie
    Allocca, Mariangela
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (10) : 1023 - 1030
  • [8] Navigating adalimumab biosimilars: an expert opinion
    Abitbol, Vered
    Benkhalifa, Salim
    Habauzit, Caroline
    Marotte, Hubert
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (11)
  • [9] Effectiveness of Adalimumab Biosimilars and Originator for Psoriasis
    Phan, Duc Binh
    Bewley, Anthony P.
    Laws, Philip
    Mackenzie, Teena
    Smith, Catherine H.
    Griffiths, Christopher E. M.
    Lunt, Mark
    Warren, Richard B.
    Yiu, Zenas Z. N.
    JAMA DERMATOLOGY, 2025,
  • [10] Toward the integration of biosimilars into pediatric rheumatology: adalimumab ABP 501 experience of PeRA research group
    Demirkan, Fatma Gul
    Ulu, Kadir
    Ozturk, Kubra
    Karadas, Serife Gul
    Ozdel, Semanur
    Sonmez, Hafize Emine
    Cakmak, Figen
    Demir, Ferhat
    Sozeri, Betul
    Ayaz, Nuray Aktay
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (02) : 197 - 202
12345